- Home
- SUPN vs WERN Comparison
SUPN vs WERN Comparison
Compare SUPN & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- WERN
- Stock Information
- Founded
- SUPN 2005
- WERN 1956
- Country
- SUPN United States
- WERN United States
- Employees
- SUPN N/A
- WERN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- WERN Trucking Freight/Courier Services
- Sector
- SUPN Health Care
- WERN Industrials
- Exchange
- SUPN Nasdaq
- WERN Nasdaq
- Market Cap
- SUPN 2.1B
- WERN 2.1B
- IPO Year
- SUPN 2012
- WERN N/A
- Fundamental
- Price
- SUPN $33.05
- WERN $33.70
- Analyst Decision
- SUPN Hold
- WERN Hold
- Analyst Count
- SUPN 2
- WERN 15
- Target Price
- SUPN $36.00
- WERN $37.47
- AVG Volume (30 Days)
- SUPN 464.2K
- WERN 689.4K
- Earning Date
- SUPN 02-25-2025
- WERN 02-06-2025
- Dividend Yield
- SUPN N/A
- WERN 1.67%
- EPS Growth
- SUPN 130.79
- WERN N/A
- EPS
- SUPN 1.07
- WERN 0.55
- Revenue
- SUPN $651,972,000.00
- WERN $3,030,258,000.00
- Revenue This Year
- SUPN $7.94
- WERN $6.29
- Revenue Next Year
- SUPN N/A
- WERN $7.67
- P/E Ratio
- SUPN $31.70
- WERN $61.50
- Revenue Growth
- SUPN 6.79
- WERN N/A
- 52 Week Low
- SUPN $25.53
- WERN $32.39
- 52 Week High
- SUPN $40.28
- WERN $42.48
- Technical
- Relative Strength Index (RSI)
- SUPN 32.98
- WERN 35.57
- Support Level
- SUPN $32.53
- WERN $34.24
- Resistance Level
- SUPN $39.99
- WERN $35.38
- Average True Range (ATR)
- SUPN 1.31
- WERN 0.99
- MACD
- SUPN -0.69
- WERN -0.08
- Stochastic Oscillator
- SUPN 6.71
- WERN 35.60
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - TTS and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.